Lyell Immunopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 05/15/2026 | 3.25 M | $65.14 M | 17.69% | 19.00% |
| GSK PLC | 05/14/2026 | 1.51 M | $30.34 M | 0.00% | 8.85% |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 05/15/2026 | 800.40 K | $16.06 M | 0.00% | 4.68% |
| ORLAND PROPERTIES LTD | 05/06/2026 | 754.70 K | $15.14 M | 0.00% | 4.42% |
| 05/15/2026 | 718.16 K | $14.41 M | 100.00% | 4.20% | |
| ALMITAS CAPITAL LLC | 05/15/2026 | 577.81 K | $11.59 M | 0.00% | 3.38% |
| FORESITE CAPITAL MANAGEMENT V, LLC | 05/15/2026 | 477.08 K | $9.57 M | 0.00% | 2.79% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 458.91 K | $9.21 M | 682.43% | 2.68% |
| CITADEL ADVISORS LLC | 05/15/2026 | 381.46 K | $7.65 M | 17.48% | 2.23% |
| VENBIO PARTNERS LLC | 05/15/2026 | 337.70 K | $6.77 M | 0.00% | 1.98% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 310.20 K | $6.22 M | 105.41% | 1.81% |
| ALPHABET INC. | 05/08/2026 | 293.26 K | $5.88 M | 0.00% | 1.72% |
| BLACKROCK, INC. | 05/13/2026 | 191.82 K | $3.85 M | 5.49% | 1.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 166.98 K | $3.35 M | 2.44% | 0.98% |
| SC CHINA HOLDING LTD | 05/15/2026 | 152.30 K | $73.10 K | 0.00% | 0.89% |
| MARSHALL WACE, LLP | 05/15/2026 | 148.52 K | $2.98 M | 102.57% | 0.87% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 116.41 K | $2.34 M | 194.79% | 0.68% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 114.49 K | $2.30 M | 18.43% | 0.67% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 102.00 K | $2.05 M | 100.00% | 0.60% |
| MIC CAPITAL MANAGEMENT UK LLP | 05/13/2026 | 87.03 K | $1.75 M | 0.00% | 0.51% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 86.93 K | $1.74 M | 100.00% | 0.51% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 85.97 K | $1.72 M | 0.64% | 0.50% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 79.10 K | $1.59 M | 100.00% | 0.46% |
| STATE STREET CORP | 05/15/2026 | 72.52 K | $1.45 M | 40.90% | 0.42% |
| JANE STREET GROUP, LLC | 05/12/2026 | 63.89 K | $1.28 M | 414.89% | 0.37% |
| MORGAN STANLEY | 05/15/2026 | 56.15 K | $1.13 M | 30.74% | 0.33% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 55.11 K | $1.11 M | 508.88% | 0.32% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 47.89 K | $959.00 K | 100.00% | 0.28% |
| RBF CAPITAL, LLC | 05/18/2026 | 44.09 K | $884.53 K | -40.88% | 0.26% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 41.08 K | $824.08 K | 0.00% | 0.24% |
| CLEARSTEAD ADVISORS, LLC | 05/06/2026 | 39.92 K | $800.72 K | 100.00% | 0.23% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 33.32 K | $668.42 K | 314.18% | 0.19% |
| UBS GROUP AG | 05/05/2026 | 31.81 K | $638.19 K | 140.96% | 0.19% |
| NORTHERN TRUST CORP | 05/14/2026 | 30.28 K | $607.42 K | 0.00% | 0.18% |
| CANADA PENSION PLAN INVESTMENT BOARD | 05/15/2026 | 29.41 K | $589.99 K | -8.41% | 0.17% |
| 05/08/2026 | 23.02 K | $461.68 K | 100.00% | 0.13% | |
| WALLEYE CAPITAL LLC | 05/13/2026 | 22.21 K | $445.47 K | 100.00% | 0.13% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 21.29 K | $427.12 K | 85.47% | 0.12% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 20.80 K | $417.25 K | 0.00% | 0.12% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 20.12 K | $403.67 K | 100.00% | 0.12% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 19.29 K | $387.04 K | 100.00% | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 18.00 K | $361.08 K | 0.00% | 0.11% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 15.97 K | $320.38 K | 100.00% | 0.09% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2026 | 13.44 K | $269.51 K | 100.00% | 0.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 13.13 K | $264.00 K | 0.00% | 0.08% |
| CITADEL ADVISORS LLC | 05/15/2026 | 12.00 K | $240.72 K | 100.00% | 0.07% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 11.59 K | $232.40 K | -25.81% | 0.07% |
| CITIGROUP INC | 05/11/2026 | 5.91 K | $118.60 K | 39.66% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 5.17 K | $103.61 K | 100.00% | 0.03% |
| DIADEMA PARTNERS LP | 05/15/2026 | 4.10 K | $82.25 K | 7.89% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lyell Immunopharma Inc institutional Ownership - FAQ's
During the previous two years, 99 institutional investors and hedge funds held shares of Lyell Immunopharma Inc. The most heavily invested institutionals were:
ARCH Venture Management, LLC: 3.25 M
GSK PLC: 1.51 M
Foresite Capital Management IV, LLC: 800,399
Orland Properties Ltd: 754,698
Almitas Capital LLC: 577,807
Foresite Capital Management V, LLC: 477,078
70.06% of Lyell Immunopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 51.34 M shares in the last 24 months. This purchase volume represents approximately $1.31 B in transactions.